Anti-CEA BiTE Monoclonal Antibody MEDI-565, Human

Known as: MEDI-565 
 

Topic mentions per year

Topic mentions per year

2010-2016
01220102016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
INTRODUCTION MEDI-565, a bispecific, single-chain antibody targeting human carcinoembryonic antigen on tumor cells and the CD3… (More)
Is this relevant?
2014
2014
Individual or combinations of somatic mutations found in genes from colorectal cancers can redirect the effects of chemotherapy… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2012
2012
MEDI-565 (also known as MT111) is a bispecific T-cell engager (BiTE®) antibody in development for the treatment of patients with… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
85 Biotechnology-derived therapies (i.e., biologics such as antibodies) are products created by living organisms (bacterial… (More)
Is this relevant?
2010
2010
Background:Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 3
  • figure 4
Is this relevant?